These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 19533752)
1. High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer. Bergeron A; Picard V; LaRue H; Harel F; Hovington H; Lacombe L; Fradet Y Int J Cancer; 2009 Sep; 125(6):1365-71. PubMed ID: 19533752 [TBL] [Abstract][Full Text] [Related]
2. MAGE-A9 mRNA and protein expression in bladder cancer. Picard V; Bergeron A; Larue H; Fradet Y Int J Cancer; 2007 May; 120(10):2170-7. PubMed ID: 17290406 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of melanoma-associated antigen A9 in renal cell carcinoma. Hatiboglu G; Pritsch M; Macher-Goeppinger S; Zöller M; Huber J; Haferkamp A; Pahernik S; Wagener N; Hohenfellner M Scand J Urol; 2013 Aug; 47(4):311-22. PubMed ID: 23140095 [TBL] [Abstract][Full Text] [Related]
4. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study. Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695 [TBL] [Abstract][Full Text] [Related]
5. Cancer testis antigen expression in primary and recurrent vulvar cancer: association with prognostic factors. Bellati F; Napoletano C; Tarquini E; Palaia I; Landi R; Manci N; Spagnoli G; Rughetti A; Panici PB; Nuti M Eur J Cancer; 2007 Nov; 43(17):2621-7. PubMed ID: 17950595 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer. Xu X; Tang X; Lu M; Tang Q; Zhang H; Zhu H; Xu N; Zhang D; Xiong L; Mao Y; Zhu J Exp Mol Pathol; 2014 Dec; 97(3):579-84. PubMed ID: 25445503 [TBL] [Abstract][Full Text] [Related]
7. High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival. Zhang S; Zhai X; Wang G; Feng J; Zhu H; Xu L; Mao G; Huang J Int J Clin Exp Pathol; 2015; 8(1):541-50. PubMed ID: 25755744 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer. Xu Y; Wang C; Zhang Y; Jia L; Huang J Sci Rep; 2015 Jul; 5():12104. PubMed ID: 26175056 [TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma. Han L; Jiang B; Wu H; Zhang S; Lu X Int J Clin Exp Pathol; 2014; 7(10):6734-42. PubMed ID: 25400753 [TBL] [Abstract][Full Text] [Related]
10. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms. Yakirevich E; Sabo E; Lavie O; Mazareb S; Spagnoli GC; Resnick MB Clin Cancer Res; 2003 Dec; 9(17):6453-60. PubMed ID: 14695148 [TBL] [Abstract][Full Text] [Related]
11. MAGE-A10 cancer/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomas. Mengus C; Schultz-Thater E; Coulot J; Kastelan Z; Goluza E; Coric M; Spagnoli GC; Hudolin T Int J Cancer; 2013 May; 132(10):2459-63. PubMed ID: 23125074 [TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study. Kocher T; Zheng M; Bolli M; Simon R; Forster T; Schultz-Thater E; Remmel E; Noppen C; Schmid U; Ackermann D; Mihatsch MJ; Gasser T; Heberer M; Sauter G; Spagnoli GC Int J Cancer; 2002 Aug; 100(6):702-5. PubMed ID: 12209610 [TBL] [Abstract][Full Text] [Related]
13. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck. Prasad ML; Jungbluth AA; Patel SG; Iversen K; Hoshaw-Woodard S; Busam KJ Head Neck; 2004 Dec; 26(12):1053-7. PubMed ID: 15515159 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of MAGE-A9 expression in patients with colorectal cancer. Zhan W; Zhang Z; Zhang Y; Ma J; Wu T; Gu Y; Li Y; Yang J Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):239-45. PubMed ID: 26516058 [TBL] [Abstract][Full Text] [Related]
15. Expression of MAGE-A1-A12 subgroups in the invasive tumor front and tumor center in oral squamous cell carcinoma. Brisam M; Rauthe S; Hartmann S; Linz C; Brands RC; Kübler AC; Rosenwald A; Müller-Richter UD Oncol Rep; 2016 Apr; 35(4):1979-86. PubMed ID: 26820613 [TBL] [Abstract][Full Text] [Related]
16. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance. Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224 [TBL] [Abstract][Full Text] [Related]
17. Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder. Xylinas E; Cha EK; Khani F; Kluth LA; Rieken M; Volkmer BG; Hautmann R; Küfer R; Chen YT; Zerbib M; Rubin MA; Scherr DS; Shariat SF; Robinson BD J Urol; 2014 Mar; 191(3):830-41. PubMed ID: 23994370 [TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide. Nishiyama T; Tachibana M; Horiguchi Y; Nakamura K; Ikeda Y; Takesako K; Murai M Clin Cancer Res; 2001 Jan; 7(1):23-31. PubMed ID: 11205913 [TBL] [Abstract][Full Text] [Related]
19. [Expression of melanoma antigen gene in urinary transitional cell carcinomas]. Geng L; Yu LZ; Du P; Ma M; Na YQ Zhonghua Wai Ke Za Zhi; 2005 May; 43(10):667-71. PubMed ID: 16008943 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer. Shigematsu Y; Hanagiri T; Shiota H; Kuroda K; Baba T; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Takenoyama M; Yasumoto K Lung Cancer; 2010 Apr; 68(1):105-10. PubMed ID: 19545928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]